The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease.

The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease.

Item
http://www.wikidata.org/entity/Q32049842
Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesDevelopment of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation.Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes.Administration of enoxaparin by continuous infusion in a naturalistic setting: analysis of renal function and safety.Low-molecular-weight heparin overdose: management by observation.Dosing low molecular weight heparins in kidney disease.Peak antifactor xa activity produced by dalteparin treatment in patients with renal impairment compared with controls.Enoxaparin should be used cautiously in patients with end-stage renal disease.Low-molecular-weight heparin administration in patients with end-stage renal disease--a comment.Prescribing patterns and outcomes of enoxaparin for anticoagulation of atrial fibrillation.Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end-stage renal disease.The pharmacokinetics of enoxaparin do not correlate with its pharmacodynamic effect in patients receiving dialysis therapies.Anti-Xa monitoring of enoxaparin for acute coronary syndromes in patients with renal disease.Life-threatening hemorrhage after dalteparin therapy in a patient with impaired renal function.
P2860

The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease.

Item
http://www.wikidata.org/entity/Q32049842
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease.
@ast
The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease.
@en
type
label
The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease.
@ast
The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease.
@en
prefLabel
The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease.
@ast
The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease.
@en
P2093
P2860
P304
P31
P356
10.1592/PHCO.21.2.169.34113
P407
P433
P478
P577
P698